Dublin, Dec. 22, 2021 (GLOBE NEWSWIRE) -- The "Ocular Drug Delivery System Market Forecast, Trend Analysis & Opportunity Assessment 2021-2031" report has been added to ResearchAndMarkets.com's offering.
The study offers a global industry analysis for 2016-2020 & an opportunity assessment for 2021-2031. The report consists of a comprehensive assessment of the most important market dynamics.
This report explains new API drug launches and regulatory approvals, key promotional strategies, and regulatory scenarios which can act as key success factors for the ocular drug delivery systems market during the forecast period.
This report covers micro and macro-economic factors that affect the market. It reviews the drivers, restrain and future opportunities in this market and the growth of market in ocular drug delivery systems sector.
The report looks at the impact of covid-19 on ocular drug delivery systems market in the base year and forecast years. It explains the global market volume analysis and forecast for the ocular drug delivery systems during the forecast period, along with the historical market and opportunity analysis of the future.
The study offers information divided into four important segments- technology, dosage form, distribution channel and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Technology
- Implantable Ocular Drug Delivery Systems
- Particulate Drug Delivery Systems
- Nano-Particle Drug Delivery System
Dosage Form
- Ophthalmic Solution
- Ophthalmic Suspension
- Ophthalmic Emulsion
- Ophthalmic Gels
- Ophthalmic Ointments
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Drug Store
- Mail Order Pharmacies
Key Topics Covered:
1. Executive Summary
2. Market Overview
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. GDP Growth Outlook
4.1.2. Global Healthcare Industry Outlook
4.1.3. Increasing Per Capita Healthcare Spending
4.1.4. Income Per Capita Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. Product Availability
4.2.2. Rising Demand of Non-Invasive Ocular Drug Delivery Techniques
4.2.3. Global Ocular Drug Delivery Systems Market Statistics
4.2.4. Increase in Technological Advancement
4.3. Market Dynamics
5. Market Context
6. COVID19 Crisis Analysis
7. Global Ocular Drug Delivery Systems Market Volume (Units) Analysis 2016-2020 and Forecast, 2021-2031
8. Global Ocular Drug Delivery Systems Market - Pricing Analysis
9. Global Ocular Drug Delivery Systems Market Value Analysis 2016-2020 and Forecast, 2021-2031
10. Global Ocular Drug Delivery Systems Market Analysis 2016-2020 and Forecast 2021-2031, by Technology
11. Global Ocular Drug Delivery Systems Market Analysis 2016-2020 and Forecast 2021-2031, by Dosage Form
12. Global Ocular Drug Delivery Systems Market Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
13. Global Ocular Drug Delivery Systems Market Analysis 2016-2020 and Forecast 2021-2031, by Region
14. North America Ocular Drug Delivery Systems Market Analysis 2016-2020 and Forecast 2021-2031
15. Latin America Ocular Drug Delivery Systems Market Analysis 2016-2020 and Forecast 2021-2031
16. Europe Ocular Drug Delivery Systems Market Analysis 2016-2020 and Forecast 2021-2031
17. South Asia Ocular Drug Delivery Systems Market Analysis 2016-2020 and Forecast 2021-2031
18. East Asia Ocular Drug Delivery Systems Market Analysis 2016-2020 and Forecast 2021-2031
19. Oceania Ocular Drug Delivery Systems Market Analysis 2016-2020 and Forecast 2021-2031
20. Middle East and Africa Ocular Drug Delivery Systems Market Analysis 2016-2020 and Forecast 2021-2031
21. Key and Emerging Countries Ocular Drug Delivery Systems Market Analysis 2016-2020 and Forecast 2021-2031
22. Market Structure Analysis
23. Competition Analysis
- Allergan Plc.
- Graybug Vision Inc.
- Ocular Therapeutix, Inc.
- Alimera Sciences
- pSivida
- Santen Pharmaceutical Co., Ltd
- Taiwan Liposome Company Ltd.
- Envisia Therapeutics
- Eyegate Pharma
- Valeant Pharmaceuticals International, Inc
- Vision Ophthalmology Group GmbH
- Clearside Biomedical
- URSAPHARM Arzneimittel GmbH
For more information about this report visit https://www.researchandmarkets.com/r/bgjml6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
